Center for Cardiovascular Health Disparities Research at Meharry Medical College

梅哈里医学院心血管健康差异研究中心

基本信息

  • 批准号:
    8083231
  • 负责人:
  • 金额:
    $ 20.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

The long-range goal of this project is to establish a comprehensive Center for Cardiovascular Health Disparities Research (CCHDR) at Meharry Medical College (MMC). MMC, located in Nashville, TN., is the largest private, historically black academic health sciences center dedicated exclusively to educating health care professionals and biomedical scientists. Development of the CCHDR is critical to the population we serve given the severe health disparity in cardiovascular disease, stroke and diabetes in Tennessee and especially the North Nashville and Bordeaux/Whites Creek communities, primary health care catchment areas for MMC. These areas are approximately 80-90% African American. According to Tennessee Department of Health statistics, in 2005 (based on 2000 - 2002 data) the rate of death from heart disease and stroke in African Americans is one and a half times that of White Tennesseans. Likewise the death rate in African Americans from diabetes (a major risk factor for heart disease, stroke and end-stage renal disease) is twice that of White Tennesseans. These statistics are even more alarming given that overall Tennessee ranks the 3rd highest in the nation for cardiovascular-related deaths (Source: Tennessee Department of Health, Office of Policy, Planning and Assessment, Division of Health Statistics). The specifics aims of this Phase I application are to: 1. Establish an External Advisory Board of accomplished cardiovascular scientists with experience in developing and administering center programs. The External Advisory Board will assist in recruiting the senior cardiovascular scientist (see below); 2. Recruit a senior cardiovascular scientist with a history of sustained independent funding and leadership experience in research programs and/or centers; and 3. Develop a five-year strategic plan that will guide the development of the Phase II application.
该项目的长期目标是在梅哈里医学院 (MMC) 建立一个综合性心血管健康差异研究中心 (CCHDR)。 MMC 位于田纳西州纳什维尔,是历史上最大的私立黑人学术健康科学中心,专门致力于教育医疗保健专业人员和生物医学科学家。鉴于田纳西州,特别是北纳什维尔和波尔多/怀茨克里克社区(MMC 的初级卫生保健服务区)在心血管疾病、中风和糖尿病方面存在严重的健康差距,CCHDR 的发展对我们服务的人群至关重要。这些地区大约 80-90% 是非裔美国人。据田纳西州卫生部统计,2005年(基于2000年至2002年的数据)非裔美国人心脏病和中风的死亡率是田纳西州白人的一倍半。同样,非裔美国人死于糖尿病(心脏病、中风和终末期肾病的主要危险因素)的死亡率是田纳西州白人的两倍。鉴于总体而言,这些统计数据更加令人震惊 田纳西州心血管相关死亡人数位居全国第三(来源:田纳西州卫生部、政策、规划和评估办公室、卫生统计司)。 第一阶段申请的具体目标是: 1. 建立一个由具有开发和管理中心项目经验的资深心血管科学家组成的外部顾问委员会。外部顾问委员会将协助招聘高级心血管科学家(见下文); 2. 招募一名在研究项目和/或中心具有持续独立资助和领导经验的资深心血管科学家;和 3. 制定五年战略计划,指导二期应用的开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John J. Murray其他文献

988-7 Endothelin ET<sub>A/B</sub> Receptor Antagonist Reduces Infarct Size: A Novel Therapy for Acute Myocardial Infarction
  • DOI:
    10.1016/0735-1097(95)92747-s
  • 发表时间:
    1995-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Joao V. Vitolaf;John Holsinger;Menryn B. Forman;Edwin K. Jackson;Masatoshi Kawana;Thomas Quertermous;John J. Murray
  • 通讯作者:
    John J. Murray
923-1 Inhibition of Neutrophil Function by Lidocaine as a Mechanism for the Beneficial Effect to Reduce Myocardial Reperfusion Injury
  • DOI:
    10.1016/0735-1097(95)91878-2
  • 发表时间:
    1995-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    João V. Vitola;John P. Holsinger;James Atkinson;Mervyn B. Forman;John J. Murray
  • 通讯作者:
    John J. Murray
923-3 Fluosol Reduces Myocardial Reperfusion Injury by Prolonged Suppression of Neutrophils by its Detergent Component (RheothRx) and not by Enhancing O<sub>2</sub>Delivery
  • DOI:
    10.1016/0735-1097(95)91880-7
  • 发表时间:
    1995-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    João V. Vitola;David A. Ingram;John P. Holsinger;James B. Atkinson;Mervyn B. Forman;John J. Murray
  • 通讯作者:
    John J. Murray
Efficacy and Safety of a Novel, Single-dose Azithromycin Microsphere Formulation Versus 10 Days of Levofloxacin for the Treatment of Acute Bacterial Sinusitis in Adults
  • DOI:
    10.1016/j.otohns.2005.04.020
  • 发表时间:
    2005-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    John J. Murray;Paz Emparanza;Eugenijus Lesinskas;Margaret Tawadrous;Jeanne D. Breen
  • 通讯作者:
    Jeanne D. Breen
Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D.
播散性组织胞浆菌病中的高钙血症。
  • DOI:
    10.1016/0002-9343(85)90300-6
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    0
  • 作者:
    John J. Murray;Craig R. Heim
  • 通讯作者:
    Craig R. Heim

John J. Murray的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John J. Murray', 18)}}的其他基金

Center for Cardiovascular Health Disparities Research at Meharry Medical College
梅哈里医学院心血管健康差异研究中心
  • 批准号:
    8289433
  • 财政年份:
    2011
  • 资助金额:
    $ 20.51万
  • 项目类别:
PARTICIPANT AND CLINICAL INTERACTIONS RESOURCE (PCIR)
参与者和临床互动资源 (PCIR)
  • 批准号:
    8359880
  • 财政年份:
    2011
  • 资助金额:
    $ 20.51万
  • 项目类别:
MULTIDISCIPLINARY TRAINING AND CAREER DEVELOPMENT ACTIVITIES
多学科培训和职业发展活动
  • 批准号:
    8359876
  • 财政年份:
    2011
  • 资助金额:
    $ 20.51万
  • 项目类别:
MMC and VICC: Partnership for Survivorship (1 of 2)
MMC 和 VICC:幸存者合作伙伴关系(2 中的 1)
  • 批准号:
    8540359
  • 财政年份:
    2010
  • 资助金额:
    $ 20.51万
  • 项目类别:
MMC and VICC: Partnership for Survivorship (1 of 2)
MMC 和 VICC:幸存者合作伙伴关系(2 中的 1)
  • 批准号:
    8326219
  • 财政年份:
    2010
  • 资助金额:
    $ 20.51万
  • 项目类别:
MULTIDISCIPLINARY TRAINING AND CAREER DEVELOPMENT ACTIVITIES
多学科培训和职业发展活动
  • 批准号:
    8173600
  • 财政年份:
    2010
  • 资助金额:
    $ 20.51万
  • 项目类别:
PARTICIPANT AND CLINICAL INTERACTIONS RESOURCE (PCIR)
参与者和临床互动资源 (PCIR)
  • 批准号:
    8173604
  • 财政年份:
    2010
  • 资助金额:
    $ 20.51万
  • 项目类别:
Meharry Medical College Minority-Based Community Clinical Oncology Program
梅哈里医学院少数民族社区临床肿瘤学项目
  • 批准号:
    8511579
  • 财政年份:
    2004
  • 资助金额:
    $ 20.51万
  • 项目类别:
Meharry Medical College Minority-Based Community Clinical Oncology Program
梅哈里医学院少数民族社区临床肿瘤学项目
  • 批准号:
    8308753
  • 财政年份:
    2004
  • 资助金额:
    $ 20.51万
  • 项目类别:
ADENOSINE AND ENDOTHELIN IN MYOCARDIAL REPERFUSION
心肌再灌注中的腺苷和内皮素
  • 批准号:
    2219767
  • 财政年份:
    1988
  • 资助金额:
    $ 20.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了